亚太地区下一代测序 (NGS) 市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太地区下一代测序 (NGS) 市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Published Report
  • Dec 2021
  • Asia-Pacific
  • 350 页面
  • 桌子數: 86
  • 图号: 34

>亚太下一代测序 (NGS) 市场,按产品(仪器、消耗品和服务)、应用(诊断、生物标志物发现、精准医疗、药物发现、农业和动物研究等)、最终用户(制药和生物技术公司、研究中心和学术和政府机构以及医院和诊所)、国家(日本、中国、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾和亚太地区其他地区)行业趋势和预测到 2029 年。

亚太地区下一代测序 (NGS) 市场

市场分析和见解:亚太地区下一代测序 (NGS) 市场

亚太地区下一代测序 (NGS) 市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,该市场的复合年增长率为 19.8%,预计到 2029 年将达到 60.3951 亿美元。越来越多地采用以基因组为重点的药理学成为下一代测序 (NGS) 市场增长的驱动力。

高通量测序,被广泛认为是“下一代”测序 (NGS),由于众多技术和功能的发展,现已融入常规临床实践,而早期的方案依赖于在临床病理学典型工作流程之外采集的样本,标准福尔马林固定、石蜡包埋样本,可更经常地用作 NGS 的起始材料。此外,正在积累用于分析和解释 NGS 数据的方案以及知识库,使临床医生能够在患者护理点更轻松地根据基因组信息采取行动。用于诊断慢性疾病的下一代测序产品种类繁多,满足了医疗机构的需求。技术进步的加快导致市场上开发出高效的下一代测序 (NGS)。 

推动下一代测序(NGS)市场增长的主要因素是下一代测序在药物开发中的应用以及主要参与者提供的广泛产品组合,而阻碍下一代测序(NGS)市场增长的因素包括下一代测序产品的高成本和产品召回。

下一代测序 (NGS) 市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和下一代测序 (NGS) 市场情景,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您创建收入影响解决方案以实现您的预​​期目标。

亚太地区下一代测序 (NGS) 市场

下一代测序 (NGS) 市场范围和市场规模

下一代测序 (NGS) 市场根据产品、应用和最终用户进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据产品,下一代测序 (NGS) 市场分为仪器、耗材和服务。2022 年,仪器部分预计将主导亚太地区下一代测序 (NGS) 市场,因为亚太地区的市场正在兴起,各公司正致力于在该地区建立潜在市场。
  • 根据应用,下一代测序 (NGS) 市场细分为诊断、药物发现、生物标志物发现、精准医疗、农业和动物研究。2022 年,诊断领域预计将主导亚太地区下一代测序 (NGS) 市场,因为中国和日本等国家正在常规诊断中使用 NGS,而印度诊断领域的 NGS 市场虽然小众,但具有上升潜力,从而推动市场
  • 根据最终用户,下一代测序 (NGS) 市场细分为医院和诊所、研究中心和学术及政府机构、制药和生物技术公司。2022 年,研究中心和学术及政府机构预计将主导下一代测序 (NGS) 市场,因为与慢性病和个性化医疗的下一代测序相关的研究主要由这些机构进行,从而推动了该细分市场的增长。

下一代测序 (NGS) 市场国家级分析

对下一代测序 (NGS) 市场进行了分析,并按上述产品、应用和最终用户提供了市场规模信息。

下一代测序 (NGS) 市场报告涵盖的国家包括中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾和亚太地区其他地区。

由于下一代测序的使用不断增加,预计亚太地区中国仪器部门将在 2022 年至 2029 年的预测期内以最高增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了亚太品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

主要市场参与者不断增加的战略活动,以提高对下一代测序 (NGS) 治疗的认识,正在推动下一代测序 (NGS) 市场的增长

下一代测序 (NGS) 市场还为您提供每个国家特定市场增长的详细市场分析。此外,它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2011 年至 2020 年的历史时期。

竞争格局和下一代测序 (NGS) 市场份额分析

下一代测序 (NGS) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对下一代测序 (NGS) 市场的关注有关。

从事下一代测序 (NGS) 的一些主要公司包括安捷伦科技公司、赛默飞世尔科技公司、QIAGEN、Illumina 公司、Bio-Rad Laboratories 公司、华大基因(华大基因集团的子公司)、Oxford Nanopore Technologies plc 以及其他国内公司。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的公司也签订了许多合同和协议,这也加速了下一代测序(NGS)市场的发展。

例如,

  • 2020 年 6 月,Bio-Rad Laboratories, Inc. 宣布与 Seegene, Inc. 建立合作伙伴关系,后者是多重分子诊断和生命科学研究领域的全球领导者,旨在进行传染病产品的临床开发和商业化。这为该公司提供了一个在全球范围内增加销售额和产品线的机会。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在下一代测序(NGS)领域的足迹,这也为组织的利润增长带来了好处。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 PESTEL'S ANALYSIS

3.2 PORTER'S FIVE FORCES MODEL

4 REGULATIONS OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE

5.1.2 INCREASE IN THE ADOPTION OF GENOME-FOCUSED PHARMACOLOGY

5.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYER

5.1.4 USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT

5.1.5 INCREASED TREND TOWARDS PERSONALIZED MEDICATION

5.2 RESTRAINTS

5.2.1 HIGH COST OF INSTRUMENT

5.2.2 DIFFICULTY IN CLINICAL NGS DATA ANALYSIS

5.2.3 CYBER SECURITY CONCERN IN GENOMICS

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER

5.3.2 PRODUCT APPROVAL IN RECENT YEARS

5.3.3 ADVANCEMENT IN NGS TECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM NGS

5.4.2 CHALLENGES FOR IMPLEMENTING NGS IN THE CLINICAL LAB

6 IMPACT OF COVID-19 ON ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) HEALTHCARE INDUSTRY

6.1 IMPACT ON PRICE

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19

6.5 CONCLUSION

7 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 INSTRUMENTS

7.2.1 HISEQ SERIES

7.2.2 MISEQ SERIES

7.2.3 ION TORRENT

7.2.4 PACBIO RS II

7.2.5 SEQUEL SYSTEM

7.2.6 SOLID

7.2.7 OTHERS

7.3 CONSUMABLE

7.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT

7.3.2 SAMPLE PREPARATION CONSUMABLES

7.3.3 OTHERS

7.4 SERVICES

7.4.1 SEQUENCING SERVICES

7.4.2 DATA MANAGEMENT

8 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 DIAGNOSTICS

8.3 BIOMARKER DISCOVERY

8.4 PRECISION MEDICINE

8.5 DRUG DISCOVERY

8.6 AGRICULTURE & ANIMAL RESEARCH

9 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER

9.1 OVERVIEW

9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

9.3 RESEARCH CENTERS & ACADEMIC AND GOVERNMENT INSTITUTES

9.4 HOSPITAL & CLINICS

10 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION

10.1 ASIA-PACIFIC

10.1.1 CHINA

10.1.2 JAPAN

10.1.3 INDIA

10.1.4 SOUTH KOREA

10.1.5 AUSTRALIA

10.1.6 SINGAPORE

10.1.7 THAILAND

10.1.8 MALAYSIA

10.1.9 INDONESIA

10.1.10 PHILIPPINES

10.1.11 REST OF ASIA-PACIFIC

11 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

12 COMPANY PROFILING

12.1 ILLUMINA, INC.

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 SWOT ANALYSIS

12.1.5 PRODUCT PORTFOLIO

12.1.6 RECENT DEVELOPMENTS

12.2 BGI (A SUBSIDIAIRY OF BGI GROUP) (2021)

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 SWOT ANALYSIS

12.2.5 PRODUCT PORTFOLIO

12.2.6 RECENT DEVELOPMENT

12.3 THERMO FISHER SCIENTIFIC INC.

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 SWOT ANALYSIS

12.3.5 PRODUCT PORTFOLIO

12.3.6 RECENT DEVELOPMENTS

12.4 QIAGEN

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 SWOT ANALYSIS

12.4.5 PRODUCT PORTFOLIO

12.4.6 RECENT DEVELOPMENTS

12.5 AGILENT TECHNOLOGIES, INC.

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 COMPANY SHARE ANALYSIS

12.5.4 SWOT ANALYSIS

12.5.5 PRODUCT PORTFOLIO

12.5.6 RECENT DEVELOPMENT

12.6 OXFORD NANOPORE TECHNOLOGIES

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 BIO-RAD LABORATORIES, INC.

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENTS

12.8X GENOMICS

12.8.1 COMPANY SNAPSHOT

12.8.2 REVENUE ANALYSIS

12.8.3 PRODUCT PORTFOLIO

12.8.4 RECENT DEVELOPMENTS

12.9 BIOMÉRIEUX SA

12.9.1 COMPANY SNAPSHOT

12.9.2 REVENUE ANALYSIS

12.9.3 PRODUCT PORTFOLIO

12.9.4 RECENT DEVELOPMENT

12.1 DNASTAR

12.10.1 COMPANY SNAPSHOT

12.10.2 PRODUCT PORTFOLIO

12.10.3 RECENT DEVELOPMENT

12.11 GENEIOUS

12.11.1 COMPANY SNAPSHOT

12.11.2 PRODUCT PORTFOLIO

12.11.3 RECENT DEVELOPMENTS

12.12 GENEWIZ, FROM AZENTA LIFE SCIENCES

12.12.1 COMPANY SNAPSHOT

12.12.2 REVENUE ANALYSIS

12.12.3 PRODUCT PORTFOLIO

12.12.4 RECENT DEVELOPMENTS

12.13 HAMILTON COMPANY

12.13.1 COMPANY SNAPSHOT

12.13.2 PRODUCT PORTFOLIO

12.13.3 RECENT DEVELOPMENT

12.14 MACROGEN, INC.

12.14.1 COMPANY SNAPSHOT

12.14.2 REVENUE ANALYSIS

12.14.3 PRODUCT PORTFOLIO

12.14.4 RECENT DEVELOPMENT

12.15 NEW ENGLAND BIOLABS

12.15.1 COMPANY SNAPSHOT

12.15.2 PRODUCT PORTFOLIO

12.15.3 RECENT DEVELOPMENT

12.16 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

12.16.1 COMPANY SNAPSHOT

12.16.2 REVENUE ANALYSIS

12.16.3 PRODUCT PORTFOLIO

12.16.4 RECENT DEVELOPMENTS

12.17 PARTEK, INCORPORATED

12.17.1 COMPANY SNAPSHOT

12.17.2 PRODUCT PORTFOLIO

12.17.3 RECENT DEVELOPMENT

12.18 PERKIN ELMER INC. (2021)

12.18.1 COMPANY SNAPSHOT

12.18.2 REVENUE ANALYSIS

12.18.3 PRODUCT PORTFOLIO

12.18.4 RECENT DEVELOPMENTS

12.19 ROCHE SEQUENCING (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)

12.19.1 COMPANY SNAPSHOT

12.19.2 REVENUE ANALYSIS (PARENT COMPANY)

12.19.3 PRODUCT PORTFOLIO

12.19.4 RECENT DEVELOPMENTS

12.2 TAKARA BIO INC.

12.20.1 COMPANY SNAPSHOT

12.20.2 REVENUE ANALYSIS

12.20.3 PRODUCT PORTFOLIO

12.20.4 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

表格列表

TABLE 1 NEXT GENERATION SEQUENCING COST PER SAMPLE

TABLE 2 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 3 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 5 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 7 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 9 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 10 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 ASIA-PACIFIC BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 ASIA-PACIFIC PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 ASIA-PACIFIC DRUG DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 ASIA-PACIFIC AGRICULTURE & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 16 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 ASIA-PACIFIC RESEARCH CENTERS & ACADEMIC AND GOVERNMENT INSTITUTES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA-PACIFIC HOSPITAL & CLINICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 20 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 21 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 22 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 23 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 24 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 25 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 26 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 27 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 28 CHINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 29 CHINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 30 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 31 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 33 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 34 JAPAN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 35 JAPAN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 36 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 37 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 39 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 40 INDIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 41 INDIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 42 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 43 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 44 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 45 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 46 SOUTH KOREA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 47 SOUTH KOREA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 48 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 51 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 52 AUSTRALIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 53 AUSTRALIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 54 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 55 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 57 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 58 SINGAPORE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 59 SINGAPORE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 60 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 62 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 63 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 64 THAILAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 THAILAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 67 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 68 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 69 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 70 MALAYSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 71 MALAYSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 72 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 73 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 74 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 75 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 76 INDONESIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 77 INDONESIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 78 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 79 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 80 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 81 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 82 PHILIPPINES CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 83 PHILIPPINES SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 84 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 86 REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION

FIGURE 11 WISE PORTFOLIO OFFERED BY MAJOR PLAYERS AND USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT IS EXPECTED TO DRIVE THE ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET IN 2021 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET

FIGURE 14 DECREASE IN COST OF PER BASE SEQUENCING

FIGURE 15 USE OF NSG IN DRUG DEVELOPMENT

FIGURE 16 REVENUE OF THE COMPANY AGILENT TECHNOLOGIES, INC.

FIGURE 17 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT, 2021

FIGURE 18 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT, 2020-2029 (USD MILLION)

FIGURE 19 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 20 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY APPLICATION, 2021

FIGURE 22 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY APPLICATION, 2020-2029 (USD MILLION)

FIGURE 23 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 24 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY END USER, 2021

FIGURE 26 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 27 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY END USER, CAGR (2022-2029)

FIGURE 28 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY END USER, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: SNAPSHOT (2021)

FIGURE 30 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY COUNTRY (2021)

FIGURE 31 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY COUNTRY (2022 & 2029)

FIGURE 32 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY COUNTRY (2021 & 2029)

FIGURE 33 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT (2022-2029)

FIGURE 34 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 19.8% during the forecast period by 2029.
The future market value of the Asia-Pacific Next Generation Sequencing (NGS) Market is expected to reach USD 6,039.51 million by 2029.
The major players in the Asia-Pacific Next Generation Sequencing (NGS) Market are Agilent Technologies, Inc., ThermoFisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., , BGI (A subsidiary of BGI Group), Oxford Nanopore Technologies plc, etc.
The countries covered in the Asia-Pacific Next Generation Sequencing (NGS) Market are China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, and rest of Asia-Pacific.